agent

(redirected from thrombolytic agent)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial.
Related to thrombolytic agent: Clot busting

agent

a person representing a business concern, esp a travelling salesman

Agent

 

in Soviet civil law, a party in a contract of agency. The agent’s duties include the performance of specified legal acts, for example, contracts of sale and management of property, in the name of and on the account of a principal party. The agent may be a legally competent (sui juris) citizen or a legal person (if this is allowed by the latter’s charter or statute). The actions performed by the agent directly generate, change, or extinguish rights and obligations of the principal.

The agent is bound to perform the agency in exact conformity with the principal’s instructions, carry out the agency personally, although in instances provided for by law the responsibilities may be transferred to another person (art. 68 of the RSFSR Civil Code), inform the principal upon demand of progress in performing the agency, submit a report on performance of the agency, and transfer to the principal any property obtained in connection with performance of the agency.

agent

One who is empowered to enter into binding transactions on behalf of another (usually called the principal).

agent

(networking)
In the client-server model, the part of the system that performs information preparation and exchange on behalf of a client or server. Especially in the phrase "intelligent agent" it implies some kind of automatic process which can communicate with other agents to perform some collective task on behalf of one or more humans.

agent

A software routine that waits in the background and performs an action when a specified event occurs. For example, agents could transmit a summary file on the first day of the month or monitor incoming data and alert the user when a certain transaction has arrived. Agents are also called "intelligent agents," "personal agents" and "bots." See mobile agent, bot and workflow.
References in periodicals archive ?
Although thrombolytic treatment dissolves clots to accelerate the resolution of PE, some authors do not support the routine use of thrombolytic agents in subjects who were normotensive with signs of right ventricular dysfunction (24-26).
A review on successive generations of streptokinase based thrombolytic agents. Int.
[10,11] In the present study, mortality benefit seen from reteplase suggests that there should be a change in the pattern of use of thrombolytic agents in India.
Two classifications of thrombolytic agents are currently available in the market: nonfibrin-specific and fibrin-specific thrombolytic medications (Vaishnavi, Mohanasrinivasan, & Subathra, 2011).
The Cochrane review also indicated that differences in clinical outcome in the tPA and SK trials may not be solely related to the thrombolytic agents themselves.
In addition, among up-to-date thrombolytic agents approved by health authorities only intravenous recombinant tissue plasminogen activator (rt-PA) is used as a systemic one.
Currently, no thrombolytic agents have an FDA-approved indication for clearance of a thrombotic occlusion in a HD catheter.
The company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases, including acute stroke.
However, the hospitals could not agree on which type of thrombolytic agent to use.
Developments in catheters and interventional neuroradiology techniques now offer the possibility of venous thrombolysis with either transvenous injection of a thrombolytic agent (tPA or urokinase) into the sinus or using catheters that allow for clot retrieval (Baker et al., 2001; Buccino et al., 2001; Chow et al., 2000; Dowd, Malek, Phatourous, & Hemphill, 1999; Ekseth et al., 1998).
This reference provides treatment profiles of over 4,200 hospitals, displaying their ranking in 17 crucial areas together with their percentages against the "top hospital." For heart attack and heart failure, figures deal with aspirin on arrival and at discharge, ACE inhibitor for LVSD, Beta blocker at arrival & upon discharge, thrombolytic agent received, PTCA received and smoking cessation advice.
Tokyo, Japan, Aug 5, 2005 - (JCNN) - Eisai has received approval for an additional indication of its thrombolytic agent, Cleactor Inj.